background
porcin
epidem
diarrhea
caus
porcin
epidem
diarrhea
viru
pedv
led
seriou
econom
loss
swine
industri
worldwid
studi
oral
recombin
lactobacillu
casei
vaccin
pedv
infect
target
intestin
microfold
cell
dendrit
cell
dc
deliv
core
neutral
epitop
coe
pedv
spike
protein
develop
celltarget
peptid
col
dendrit
celltarget
peptid
dcpep
immunogen
oral
administ
recombin
strain
evalu
result
immun
significantli
higher
level
antipedv
specif
igg
antibodi
pedv
neutral
activ
sera
mucos
siga
antibodi
tractu
genitali
intestin
mucu
stool
detect
mice
oral
administ
recombin
strain
express
dcpep
col
target
ligand
fuse
pedv
coe
antigen
compar
mice
oral
immun
recombin
strain
without
dcpep
col
target
ligand
moreov
respons
restimul
pedv
coe
antigen
vitro
signific
differ
splenocyt
prolifer
respons
cytokin
level
observ
group
mice
oral
immun
p
compar
group
mice
receiv
respect
intestin
cellsand
dcstarget
oral
deliveri
genet
engin
lactobacillu
express
coe
antigen
pedv
effici
induc
antipedv
mucos
humor
cellular
immun
respons
via
oral
administr
suggest
promis
vaccin
strategi
pedv
infect
porcin
epidem
diarrhea
ped
character
vomit
diarrhea
dehydr
highli
contagi
intestin
diseas
caus
porcin
epidem
diarrhea
viru
pedv
pedv
member
coronavirida
famili
envelop
singlestrand
rna
viru
whose
genom
compris
five
open
read
frame
orf
encod
accessori
protein
four
structur
protein
spike
surfac
pedv
mediat
bind
fusion
viru
cell
addit
neutral
epitop
region
pedv
coe
shown
induc
viru
neutral
antibodi
use
potenti
candid
immunogen
pedv
pedv
caus
seriou
econom
loss
swine
industri
europ
america
australia
especi
asia
current
commerci
vaccin
mostli
includ
inactiv
vaccin
attenu
pedv
vaccin
provid
protect
efficaci
poor
sinc
pedv
caus
mainli
intestin
infect
secretori
iga
siga
bind
microb
toxin
intestin
prevent
adher
epitheli
cell
desir
defend
mucosa
pedv
thu
research
vaccin
induc
efficaci
sigabas
protect
mucos
immun
urgent
need
prevent
pedv
infect
oral
mucos
vaccin
great
advantag
improv
practic
mass
vaccin
pandem
along
eas
product
administr
local
protect
mucos
immun
pivot
respons
pedv
invas
gener
induc
parenter
vaccin
induct
mucos
immun
focus
interact
antigen
lymphocyt
within
mucosa
one
promis
approach
involv
use
live
recombin
lactobacillu
colon
gastrointestin
tract
compet
pathogen
mucos
bind
site
cell
wall
associ
secret
factor
lactobacillu
strain
enhanc
innat
immun
respons
epitheli
barrier
function
modul
intestin
microenviron
regul
immun
cell
behavior
elicit
releas
cytokin
addit
natur
immunestimul
adjuv
weak
immunogen
capac
surviv
gastric
acid
digest
enzym
sever
lactobacillu
strain
appli
deliveri
heterolog
antigen
trigger
mucos
immun
respons
pathogen
although
live
recombin
lactobacillu
vaccin
propag
porcin
intestin
small
amount
antigen
reach
effect
immun
site
peyer
patch
pp
increas
bioavail
immunogen
interest
addit
dendrit
celltarget
peptid
dcpep
microfold
cell
cell
target
peptid
col
oral
lactobacillu
deliveri
system
propos
microbi
sampl
commonli
includ
two
princip
mechan
cell
predominantli
local
pp
transfer
antigen
dc
macrophag
process
dc
pierc
epitheli
layer
sampl
antigen
directli
previou
studi
demonstr
dcpep
direct
protect
antigen
dc
use
lactobacillu
vector
induc
desir
intestin
system
immun
respons
furthermor
cell
ligandfus
antigen
shown
enhanc
specif
mucos
immun
respons
combin
target
dc
cell
simultan
may
strengthen
improv
antigen
uptak
present
therefor
present
studi
genet
engin
lactobacillu
casei
l
casei
strain
construct
constitut
express
coe
pedv
either
one
dcpep
col
cell
surfac
immunogen
recombin
strain
investig
oral
administr
mice
pedv
isol
intestin
piglet
sever
diarrhea
heilongjiang
china
maintain
laboratori
lactobacillu
casei
atcc
cultur
de
man
rogosa
sharp
mr
broth
constitut
express
plasmid
previous
construct
laboratori
contain
hce
strong
constitut
promot
transcript
enhanc
pgsa
anchor
bacillu
subtili
stabil
heterolog
protein
cell
membran
surfacedisplay
termin
use
construct
coe
plasmid
describ
recombin
express
plasmid
construct
shown
fig
nucleic
acid
manipul
clone
procedur
perform
accord
standard
procedur
total
viru
rna
extract
use
commerci
kit
fastagen
shanghai
china
firststrand
cdna
transcrib
revert
aid
mmlv
revers
transcriptas
fermenta
new
york
usa
briefli
rna
incub
l
revers
primer
coe
min
subsequ
ml
rnase
inhibitor
g
ml
ml
dntp
mix
ml
revertaid
mmulv
revers
transcriptas
ad
mix
gentli
centrifug
incub
h
reaction
termin
heat
min
cdna
templat
use
polymeras
chain
reaction
pcr
primer
design
spike
gene
pedv
genbank
access
list
tabl
primer
name
use
obtain
coe
gene
without
target
peptid
use
coe
gene
pcr
templat
primer
get
coecoldcpep
revers
primer
name
contain
sequenc
target
peptid
fuse
dcpep
col
c
terminu
coe
flexibl
linker
gggg
insert
two
target
peptid
flexibl
amino
acid
gs
insert
coe
target
peptid
swissmodel
use
predict
fuse
protein
structur
coecoldcpep
fusion
gene
clone
express
plasmid
gener
construct
recombin
lactobacillu
strain
recombin
plasmid
electrotransf
l
casei
describ
previous
give
rise
recombin
strain
addit
also
gener
maintain
laboratori
briefli
ml
recombin
l
casei
grown
mr
broth
contain
chloramphenicol
ml
h
od
harvest
centrifug
wash
twice
steril
pb
lysi
sediment
cell
lysozym
lysat
incub
sodium
dodecyl
sulfat
sd
load
buffer
boil
water
bath
min
bacteri
protein
separ
sdspolyacrylamid
gel
electrophoresi
sdspage
electrotransf
onto
polyvinyliden
fluorid
pvdf
membran
immunoblot
probe
mous
antico
serum
prepar
laboratori
primari
antibodi
horseradish
peroxidas
hrp
conjug
goat
antimous
igg
secondari
antibodi
furthermor
detect
surfacedisplay
coe
target
peptid
recombin
l
casei
immunofluoresc
use
describ
previous
brief
recombin
strain
cultur
overnight
mr
cell
pellet
subsequ
incub
antipedv
coe
serum
follow
fluorescein
isothiocyanateconjug
goat
antimous
igg
invitrogen
usa
secondari
antibodi
sampl
wash
thrice
pb
stain
dapi
invitrogen
usa
min
wash
three
time
resuspend
pb
smear
microscop
slide
imag
view
laser
confoc
microscopi
model
meta
zeiss
germani
sixweekold
femal
specif
pathogenfre
spf
balbc
mice
purchas
liaon
changsheng
biotechnolog
compani
liaon
china
kept
spf
condit
free
access
standard
water
diet
anim
procedur
approv
ethic
committe
anim
experi
northeast
agricultur
univers
harbin
china
prior
oral
administr
recombin
lactobacillu
strain
cultur
overnight
mr
medium
wash
steril
pb
resuspend
pb
concentr
cfu
ml
sixti
mice
randomli
divid
six
group
mice
per
group
pb
ppgcoe
ppg
group
immun
dosag
cfu
per
mice
administ
consecut
day
day
booster
immun
administ
day
serum
mucos
lavag
sampl
extern
genit
tract
obtain
day
immun
immun
mice
five
mice
group
sacrif
collect
intestin
tract
duodenum
ileum
primari
immun
five
mice
sacrif
day
immun
collect
intestin
tract
spleen
follow
wash
steril
pb
sampl
intestin
tract
store
analysi
addit
fecal
sampl
collect
day
immun
treat
accord
previous
describ
method
briefli
g
fecal
pellet
suspend
pb
contain
mmol
l
phenylmethylsulfonyl
fluorid
sigma
usa
bovin
serum
albumin
bsa
incub
h
centrifug
supernat
store
use
level
igg
sera
iga
extern
genit
tract
intestin
tract
stool
measur
elisa
polystyren
microtit
plate
coat
overnight
pedv
nj
propag
vero
cell
cultur
vero
cell
use
neg
control
antigen
block
skim
milk
collect
sampl
serial
dilut
pb
ad
triplic
incub
h
hrpconjug
goat
antimous
igg
iga
antibodi
invitrogen
usa
ad
well
incub
h
color
develop
use
ophenylenediamin
dihydrochlorid
sigma
usa
substrat
absorb
od
measur
day
postimmun
splenocyt
obtain
immun
mice
subject
euthanasia
lymphocyt
prolifer
assay
brief
cell
suspens
cell
ml
eight
duplic
four
prepar
cytokin
elisa
incub
plate
contain
rpmi
medium
plu
fetal
calf
serum
co
incub
cell
restimul
ml
concanavalin
cona
ml
purifi
recombin
coe
protein
cultur
medium
h
control
well
contain
medium
alon
lymphocyt
prolifer
assess
celltit
aqueou
nonradioact
cell
prolifer
assay
accord
manufactur
instruct
promega
usa
absorb
measur
nm
stimul
index
calcul
follow
si
od
sampl
od
blank
control
supernat
fluid
lymphocyt
prolifer
assay
collect
h
assay
perform
use
elisa
kit
accord
manufactur
instruct
biosourc
intern
usa
cytokin
concentr
calcul
accord
standard
curv
obtain
elisa
plate
briefli
sera
mice
day
postimmun
filter
inactiv
min
sera
serial
dilut
twofold
mix
equal
volum
viru
suspens
incub
h
intermixtur
inocul
onto
vero
cell
monolay
co
incub
posit
serum
control
neg
serum
control
viru
control
blank
control
prearrang
cytopath
effect
cpe
observ
daili
reedmuench
statist
method
use
calcul
result
data
shown
mean
standard
error
three
replic
per
test
singl
experi
repeat
three
time
tukey
multipl
comparison
test
use
analyz
differ
group
p
valu
less
consid
statist
signific
p
valu
less
consid
highli
signific
ensur
structur
antigen
target
peptid
interf
structur
fuse
protein
predict
shown
addit
file
dcpep
expos
c
terminu
coe
interfer
coe
establish
oral
vaccin
deliveri
system
construct
plasmid
success
transform
lactobacillu
recombin
lactobacillu
strain
cultur
mr
broth
h
express
coe
determin
western
blot
mous
antico
polyclon
antibodi
shown
fig
fusion
protein
kda
consist
predict
molecular
weight
neg
control
display
correspond
immunoreact
band
laser
confoc
microscopi
use
determin
whether
fusion
protein
express
surfac
lactobacillu
cell
shown
fig
cell
incub
fitcconjug
secondari
antibodi
stain
dapi
fig
fig
fig
fig
emit
green
fluoresc
cellular
surfac
wherea
fig
indic
fusion
protein
display
surfac
bacteria
immunogen
recombin
lactobacillu
strain
mice
oral
immun
evalu
specif
mucos
system
immun
respons
assess
detect
presenc
antipedv
igg
iga
antibodi
elisa
respect
scheme
oral
immun
specimen
collect
shown
fig
result
show
significantli
higher
level
antigenspecif
system
igg
antibodi
fig
day
p
day
p
antigenspecif
mucos
siga
antibodi
tractu
genitali
fig
day
p
day
p
postimmun
mice
oral
administ
recombin
strain
compar
group
compar
result
observ
siga
antibodi
intestin
mucu
day
postimmun
fig
figur
show
trend
siga
level
stool
primari
immun
siga
antibodi
level
rose
rapidli
peak
day
subsequ
declin
day
booster
immun
siga
antibodi
level
increas
rapidli
reach
peak
day
peak
valu
significantli
higher
first
immun
siga
antibodi
induc
recombin
strain
target
ligand
group
increas
faster
induc
group
sixth
day
stool
howev
differ
among
coecol
coedcpep
coecoldcpep
group
igg
siga
signific
p
prolifer
splenocyt
upon
stimul
coe
protein
analyz
mtt
assay
result
show
increas
concentr
purifi
coe
protein
prolifer
splenocyt
mice
follow
trend
shown
fig
ppgcoecoldcpep
ppgcoedcpep
p
cytokin
elisa
cultur
supernat
harvest
h
show
respons
coe
splenocyt
mice
oral
administ
recombin
l
casei
express
coecoldcpep
coecol
coedcpep
produc
higher
level
cytokin
fig
cytokin
fig
compar
mice
administ
recombin
l
casei
express
coe
splenocyt
prolifer
trend
observ
level
p
neutral
activ
sera
mice
oral
administ
recombin
l
casei
evalu
current
pedv
caus
signific
econom
loss
high
mortal
loss
product
subsequ
attenu
inactiv
pedv
vaccin
develop
reason
unknown
vaccin
base
classic
pedv
strain
fail
control
recent
virul
pedv
strain
asia
evolut
develop
effect
vaccin
pedv
never
ceas
due
presenc
epidem
variant
strain
protein
coronavirus
report
respons
bind
cellular
receptor
earli
step
infect
induc
neutral
antibodi
vivo
immunogen
base
local
viru
isol
may
help
prevent
control
outbreak
region
studi
gene
homolog
coe
amino
acid
protein
classic
pedv
strain
strain
coe
clone
studi
show
insert
delet
gene
sequenc
parenter
vaccin
gener
fail
induc
mucos
immun
pedv
infect
local
oral
vaccin
stimul
protect
mucos
immun
respons
well
crucial
passiv
lactogen
immun
recent
studi
suggest
success
gener
pedv
neutral
antibodi
milk
depend
oral
immun
oral
exposur
sow
serum
igg
antibodi
may
correl
immun
pedv
igg
domin
colostrum
decreas
sow
milk
time
siga
account
total
milk
antibodi
order
deliv
coe
gastrointestin
tract
oral
administr
genet
engin
lactobacillu
constitut
surfacedisplay
coe
construct
particul
antigen
induct
immun
respons
immunocyt
memori
l
casei
surviv
bile
salt
low
ph
gastrointestin
tract
well
colon
intestin
mice
swine
day
enhanc
system
mucos
immun
respons
oral
administ
antigen
constitut
express
without
induc
gener
prefer
situ
deliveri
antigen
lactobacillu
consider
product
stabil
high
cost
induc
one
essenti
consider
oral
vaccin
immunogen
need
penetr
gut
wall
epitheli
cell
line
tightli
taken
antigen
present
cell
influenc
immun
effici
antigen
sampl
occur
transcytosi
membran
cell
well
dendrit
extens
dendrit
cell
lumen
view
l
casei
strain
express
mammalian
dcpep
col
fuse
separ
togeth
immunogen
target
vaccin
evalu
immun
effici
mice
theoret
recombin
lactobacillu
first
adher
intestin
mucu
compet
bind
epitop
pathogen
bacteria
simultan
recombin
lactobacillu
guid
col
bind
receptor
cell
import
dome
area
gut
associ
lymphoid
tissu
dc
present
dcpep
allow
coe
captur
dc
bind
receptor
moreov
coe
fuse
dcpep
directli
engulf
dc
dendrit
epitheli
cell
protect
immun
also
elicit
activ
b
cell
secret
siga
activ
cell
differenti
dc
present
process
coe
b
cell
directli
migrat
mesenter
lymph
node
antigen
present
dcactiv
b
cell
migrat
peripheri
induc
specif
immun
pathogen
challeng
fig
lymphocyt
prolifer
determin
mtt
assay
respons
recombin
coe
protein
concanavalin
stimul
agent
immun
mice
bar
repres
mean
standard
error
valu
group
differ
letter
indic
signific
differ
p
fig
cytokin
level
spleen
cell
immun
mice
purifi
core
neutral
epitop
coe
ad
cultur
spleen
cell
stimul
gamma
interferon
b
detect
differ
letter
indic
signific
differ
p
letter
indic
signific
differ
p
data
show
recombin
strain
target
ligand
like
recruit
dc
cell
promot
rapid
stronger
immun
respons
mucos
system
level
compar
induc
studi
coecol
coedcpep
coecoldcpep
group
show
higher
siga
level
fece
compar
coe
group
sixth
day
post
immun
higher
igg
siga
tractu
genitali
day
post
immun
illustr
earli
stage
target
ligand
help
elicit
better
immunogen
rapidli
especi
siga
level
indic
signific
oral
vaccin
evalu
effect
cellular
immun
splenocyt
prolifer
cytokin
level
determin
differenti
effect
specif
cellmedi
immun
depend
adjuv
dosag
lactobacillu
strain
antigen
use
higher
level
vaccin
group
control
group
illustr
cellular
immun
respons
induc
trend
splenocyt
prolifer
level
indic
target
ligand
may
enhanc
product
memori
lymphocyt
humor
immun
coecoldcpep
group
coecol
group
coedcpep
group
coe
group
pb
group
p
relev
research
also
demonstr
target
peptid
enhanc
antigenspecif
igg
iga
cell
respons
report
antibodi
level
mice
oral
administr
lactobacillu
express
antigendcpep
compar
mice
group
vaccin
antigenadjuv
singl
subcutan
inject
anoth
research
show
ligand
induc
oral
toler
use
result
skew
immun
respons
addit
evalu
neutral
antibodi
neutral
viral
pathogen
bind
epitop
antigen
associ
viru
neutral
neutral
part
viru
infect
cycl
inhibit
includ
cellular
surfac
bind
fusion
entri
endocytosi
replic
neutral
antibodi
provid
qualiti
correl
vaccin
efficaci
mani
licens
vaccin
assess
pedvneutr
activ
illustr
coecoldcpep
group
best
neutral
potenti
suggest
may
promis
vaccin
candid
pedv
infect
mucos
immun
system
properli
balanc
pathogen
surveil
toler
dietari
antigen
commens
microb
indic
mucos
antigen
gener
less
immunogen
antigen
deliv
rout
potent
adjuv
deliveri
platform
requir
effect
mucos
vaccin
report
dcpep
would
reduc
need
adjuv
enhanc
immun
respons
mucos
adjuv
abil
studi
l
casei
colon
intestin
transient
appli
deliveri
vector
potent
adjuv
moreov
target
ligand
favor
increas
bioavail
vaccin
help
elicit
mucos
system
immun
respons
studi
focu
swine
zooperi
investig
immun
efficaci
protect
although
balbc
mous
suscept
anim
model
pedv
result
extent
indic
surfacedisplay
coecoldcpep
l
casei
could
serv
novel
mucos
vaccin
provid
opportun
pedv
vaccin
develop
use
l
casei
antigen
carrier
deliv
coe
fuse
cell
dc
target
ligand
oral
vaccin
result
show
ppgcoecoldcpep
abl
effect
induc
immun
respons
mucos
system
level
compar
moreov
found
l
casei
deliv
coe
antigen
combin
dcpep
col
promot
stronger
rapid
antigenspecif
immun
respons
mice
suggest
promis
strategi
vaccin
develop
pedv
infect
